Tonix Pharmaceuticals Hol...

15.65
-0.21 (-1.32%)
At close: Apr 17, 2025, 3:59 PM
15.79
0.89%
After-hours: Apr 17, 2025, 07:59 PM EDT
-1.32%
Bid 11.5
Market Cap 107.64M
Revenue (ttm) 10.09M
Net Income (ttm) -130.04M
EPS (ttm) -176.6
PE Ratio (ttm) -0.09
Forward PE -3.35
Analyst Strong Buy
Ask 19.85
Volume 296,949
Avg. Volume (20D) 1,722,831
Open 15.65
Previous Close 15.86
Day's Range 15.62 - 16.09
52-Week Range 6.76 - 672.00
Beta 1.51

About TNXP

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, auto...

Industry Biotechnology
Sector Healthcare
IPO Date May 10, 2012
Employees 81
Stock Exchange NASDAQ
Ticker Symbol TNXP
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for TNXP stock is "Strong Buy." The 12-month stock price forecast is $585, which is an increase of 3638.02% from the latest price.

Stock Forecasts

Next Earnings Release

Tonix Pharmaceuticals Holding Corp. is scheduled to release its earnings on May 12, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+32.48%
Tonix Pharmaceutical shares are trading higher aft... Unlock content with Pro Subscription
1 month ago
-19.78%
Tonix Pharmaceuticals Holdings shares are trading lower after the company reported mixed Q4 financial results.